Medtronic plc (NYSE: MDT) is a company in the Health Care sector, listed on the NYSE. This page collects all Alpha Stocks Insight coverage of MDT: earnings reports, analyst actions, and company news, updated as new articles are published. 3 articles since June 3, 2026.
Split analyst calls on MDT: BTIG upgrades to Buy with a $90 target while UBS trims its target to $85 — here's what it means for MDT investors.
Medtronic submitted 510(k) applications covering general surgery indications for its Hugo RAS system — here's what the FDA filing means for MDT investors.
Medtronic beat Q4 FY2026 EPS and revenue estimates, with executives calling it the strongest top-line quarter in 10 years — here's what it means for MDT investors.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.